Schrödinger, Inc. (NASDAQ:SDGR) Insider Karen Akinsanya Sells 16,723 Shares

Schrödinger, Inc. (NASDAQ:SDGR) insider Karen Akinsanya sold 16,723 shares of the business’s stock in a transaction that occurred on Monday, April 14th. The stock was sold at an average price of $25.09, for a total value of $419,580.07. Following the transaction, the insider now directly owns 15,625 shares in the company, valued at $392,031.25. This trade represents a 51.70 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Schrödinger Stock Down 3.6 %

Schrödinger stock opened at $25.59 on Wednesday. The company’s 50-day moving average price is $21.98 and its two-hundred day moving average price is $20.84. The stock has a market cap of $1.87 billion, a P/E ratio of -10.94 and a beta of 1.77. Schrödinger, Inc. has a twelve month low of $16.60 and a twelve month high of $28.47.

Schrödinger (NASDAQ:SDGR) last announced its earnings results on Wednesday, February 26th. The company reported ($0.55) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.20). The firm had revenue of $88.32 million for the quarter, compared to the consensus estimate of $83.20 million. Schrödinger had a negative return on equity of 35.77% and a negative net margin of 91.84%. Equities analysts anticipate that Schrödinger, Inc. will post -2.37 earnings per share for the current fiscal year.

Analyst Ratings Changes

SDGR has been the subject of a number of research analyst reports. Piper Sandler reduced their price target on Schrödinger from $50.00 to $45.00 and set an “overweight” rating for the company in a report on Thursday, February 27th. KeyCorp raised their price objective on Schrödinger from $25.00 to $27.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. One investment analyst has rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of $32.29.

Institutional Investors Weigh In On Schrödinger

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Greenwood Capital Associates LLC grew its stake in shares of Schrödinger by 2.7% in the first quarter. Greenwood Capital Associates LLC now owns 23,139 shares of the company’s stock valued at $457,000 after acquiring an additional 612 shares in the last quarter. GAMMA Investing LLC boosted its holdings in Schrödinger by 118.5% in the 1st quarter. GAMMA Investing LLC now owns 6,109 shares of the company’s stock valued at $121,000 after purchasing an additional 3,313 shares during the period. Harbor Capital Advisors Inc. grew its position in shares of Schrödinger by 32.4% during the 1st quarter. Harbor Capital Advisors Inc. now owns 15,005 shares of the company’s stock worth $296,000 after purchasing an additional 3,676 shares in the last quarter. United Advisor Group LLC increased its holdings in shares of Schrödinger by 3.3% during the fourth quarter. United Advisor Group LLC now owns 19,769 shares of the company’s stock worth $381,000 after purchasing an additional 634 shares during the period. Finally, Two Sigma Advisers LP acquired a new stake in shares of Schrödinger in the fourth quarter valued at approximately $473,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

About Schrödinger

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.